---
title: Noble Life Sciences vs uBriGene
slug_a: noblelifesci
slug_b: ubrigene
site: cro
review_signal_gate: closed
canonical_path: /compare/noblelifesci/ubrigene
---

# Noble Life Sciences vs uBriGene

Side-by-side profile data from each company listing on this directory.

## Noble Life Sciences

- Profile: [/companies/noblelifesci](/companies/noblelifesci)

Noble Life Sciences — Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.

Services: 12. Modalities: 6. Indications: 3. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Discovery Research
- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- Analytical Method Development & Validation
- Translational Research
- Virology Services
- Immunology & Inflammation Services
- Oncology Specialty Services

### Modalities

- Small Molecule
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
- Synthetic Biology

### Indications

- Oncology
- Immunology
- Infectious Disease

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## uBriGene

- Profile: [/companies/ubrigene](/companies/ubrigene)

uBriGene — uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. The strongest documented coverage currently appears in services (5).

### Services

- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- China NMPA Regulatory Strategy
- Analytical Method Development & Validation
- Translational Research

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)